MICROBA LIFE SCIENCES LIMITED - Announcements

0.00%

9.2¢

Market Cap $47.38M

Healthcare Medical Care

Microba Life Sciences Limited is an Australia-based precision microbiome company. The... Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

MAP	Q4 FY25 Quarterly Investor Presentation & Webinar	PRICE SENSITIVE	22/07/25	4.23MB	Share
MAP	Q4 FY25 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	22/07/25	528.6KB	Share
MAP	Details of Q4 FY25 Quarterly Report, Appendix 4C & Webinar		17/07/25	160KB	Share
MAP	Letter to Shareholders, Notice of EGM & Proxy Form		08/07/25	902.1KB	Share
MAP	Ceasing to be a substantial holder		02/07/25	205.24KB	Share
MAP	Cleansing Notice		27/06/25	170.84KB	Share
MAP	Letter to SPP Eligible Shareholders		27/06/25	247.16KB	Share
MAP	Disclosure Document - Prospectus	PRICE SENSITIVE	27/06/25	891.75KB	Share
MAP	Application for quotation of securities - MAP		27/06/25	15.8KB	Share
MAP	Reinstatement to Quotation	PRICE SENSITIVE	23/06/25	86.15KB	Share
MAP	Proposed issue of securities - MAP		23/06/25	24.4KB	Share
MAP	Proposed issue of securities - MAP		23/06/25	16.69KB	Share
MAP	Proposed issue of securities - MAP		23/06/25	19.09KB	Share
MAP	Proposed issue of securities - MAP		23/06/25	15.57KB	Share
MAP	Strategic Investment & Equity Raise Presentation	PRICE SENSITIVE	23/06/25	4.96MB	Share
MAP	Microba secures $14.5 million to drive clinical adoption	PRICE SENSITIVE	23/06/25	348.74KB	Share
MAP	Suspension from Quotation	PRICE SENSITIVE	23/06/25	270.19KB	Share
MAP	Trading Halt	PRICE SENSITIVE	19/06/25	265.94KB	Share
MAP	MetaPanel Pathogen Study Delivers Breakthrough Results	PRICE SENSITIVE	21/05/25	246.16KB	Share
MAP	Landmark GI Study Results from over 4,600 patients	PRICE SENSITIVE	14/05/25	236.25KB	Share
MAP	Notification of cessation of securities - MAP		12/05/25	12.83KB	Share
MAP	Q3 FY25 Quarterly Investor Presentation & Webinar	PRICE SENSITIVE	30/04/25	2.83MB	Share
MAP	Q3 FY25 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/04/25	446.4KB	Share
MAP	Details of Q3 FY25 Quarterly Report, Appendix 4C & Webinar		28/04/25	139.54KB	Share
MAP	HealthInvest 2025 Investor Conference Presentation		02/04/25	2.08MB	Share
MAP	Webinar Presentation - Diagnostics Deep Dive - Part A		20/03/25	5.17MB	Share
MAP	Diagnostics Growth & Metrics Webinar - Part B		20/03/25	492.81KB	Share
MAP	Investor Webinar & Newsletter		04/03/25	240.75KB	Share
MAP	Appendix 4D & FY25 Interim Report	PRICE SENSITIVE	26/02/25	2.37MB	Share
MAP	Notification of cessation of securities - MAP		19/02/25	12.89KB	Share
MAP	Notification of cessation of securities - MAP		19/02/25	12.89KB	Share
MAP	Notification regarding unquoted securities - MAP		14/02/25	18.6KB	Share
MAP	Q2 FY25 Quarterly Investor Presentation & Webinar	PRICE SENSITIVE	29/01/25	4.05MB	Share
MAP	Q2 FY25 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/01/25	368.92KB	Share
MAP	Details of Q2 FY25 Quarterly Report, Appendix 4C & Webinar		23/01/25	145.24KB	Share
MAP	Becoming a substantial holder		03/01/25	209.94KB	Share
MAP	Amended Constitution		29/11/24	688.99KB	Share
MAP	Results of Annual General Meeting		29/11/24	160.8KB	Share
MAP	2024 Annual General Meeting Presentation		29/11/24	3.25MB	Share
MAP	Chair, Deputy Chair and CEO Addresses to AGM		29/11/24	226.88KB	Share
MAP	Trading Update	PRICE SENSITIVE	29/11/24	167.5KB	Share
MAP	Change of Director's Interest Notice - Pasquale Rombola		20/11/24	271.95KB	Share
MAP	Change of Director's Interest Notice - Prof Ian Frazer		20/11/24	272KB	Share
MAP	Bell Potter Healthcare Conference Presentation		19/11/24	3.56MB	Share
MAP	Microba receives $6 million R&D Tax Incentive Refund	PRICE SENSITIVE	18/11/24	166.11KB	Share
MAP	Release of Securities from Voluntary Escrow		11/11/24	138.87KB	Share
MAP	Q1 FY25 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/10/24	414.76KB	Share
MAP	Q1 FY25 Quarterly Investor Presentation	PRICE SENSITIVE	29/10/24	4.23MB	Share
MAP	Annual Report to Shareholders		28/10/24	4MB	Share
MAP	Letter to Shareholders, Notice of AGM & Proxy Form		28/10/24	599.75KB	Share
MAP	Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar		23/10/24	145.26KB	Share
MAP	Strategic transfer of Microba Research Services Unit to CMC		10/10/24	176.29KB	Share
MAP	Date of AGM and Closing Date for Director Nominations		02/10/24	132.53KB	Share
MAP	Microba Presents at ASX Small & Mid Cap Conference		25/09/24	3.01MB	Share
MAP	Change of Joint Company Secretary Role		02/09/24	132.05KB	Share
MAP	2024 Annual Report & Appendix 4E	PRICE SENSITIVE	29/08/24	4.28MB	Share
MAP	2024 Appendix 4G		29/08/24	287.71KB	Share
MAP	2024 Corporate Governance Statement		29/08/24	240.75KB	Share
MAP	Q4 FY24 Quarterly Investor Presentation & Webinar	PRICE SENSITIVE	25/07/24	2.85MB	Share
MAP	Q4 FY24 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	25/07/24	410.05KB	Share
MAP	Details of Q4 FY24 Quarterly Report, Appendix 4C & Webinar		23/07/24	145KB	Share
MAP	Microba Diagnostics Business Update to Bioshares Summit		12/07/24	1.36MB	Share
MAP	Notification of cessation of securities - MAP		10/07/24	14.82KB	Share
MAP	Completion of Autoimmune Program with Ginkgo Bioworks	PRICE SENSITIVE	28/06/24	240.98KB	Share
MAP	Release of Securities from Voluntary Escrow		25/06/24	128.08KB	Share
MAP	Notification of cessation of securities - MAP		03/06/24	12.88KB	Share
MAP	Q3 FY24 Quarterly Investor Presentation	PRICE SENSITIVE	23/04/24	3.8MB	Share
MAP	Q3 FY24 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	23/04/24	415.6KB	Share
MAP	Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar		18/04/24	142.29KB	Share
MAP	Microba Launches Investor Hub for Investor Engagement		16/04/24	161.93KB	Share
MAP	Microba receives $6.08 million R&D Tax Incentive Refund	PRICE SENSITIVE	10/04/24	156.94KB	Share
MAP	Notification of cessation of securities - MAP		10/04/24	12.94KB	Share
MAP	Ceasing to be a substantial holder		05/04/24	217.69KB	Share
MAP	Application for quotation of securities - MAP		05/04/24	14.34KB	Share
MAP	Release of Restricted Securities		25/03/24	150.33KB	Share
MAP	MetaPanel Launch Investor Presentation	PRICE SENSITIVE	13/03/24	2.01MB	Share
MAP	MetaPanel Diagnostic Test Launched with Sonic Healthcare	PRICE SENSITIVE	13/03/24	252.04KB	Share
MAP	Change in substantial holding		04/03/24	270.91KB	Share
MAP	Appendix 4D & FY24 Interim Report	PRICE SENSITIVE	28/02/24	2.03MB	Share
MAP	Change in substantial holding		26/02/24	230.09KB	Share
MAP	Q2 FY24 Quarterly Investor Presentation	PRICE SENSITIVE	30/01/24	4.09MB	Share
MAP	Q2 FY24 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/01/24	381.9KB	Share
MAP	Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar		29/01/24	130.4KB	Share
MAP	Notification of cessation of securities - MAP		25/01/24	21.78KB	Share
MAP	Release of Restricted Securities		19/01/24	150.39KB	Share
MAP	Notification regarding unquoted securities - MAP		29/12/23	28.17KB	Share
MAP	Change of Director's Interest Notice - Jacqueline Fernley		29/12/23	261.62KB	Share
MAP	Successful IBD Phase I Clinical Trial	PRICE SENSITIVE	07/12/23	233.97KB	Share
MAP	Cleansing Notice		06/12/23	198.24KB	Share
MAP	Application for quotation of securities - MAP		06/12/23	24.98KB	Share
MAP	Completion of Acquisition of Invivo Clinical Limited		06/12/23	138.15KB	Share
MAP	Proposed issue of securities - MAP		04/12/23	25.31KB	Share
MAP	Proposed issue of securities - MAP		04/12/23	25.22KB	Share
MAP	Research Agreement Executed with IFF for Allergy Program	PRICE SENSITIVE	04/12/23	168.71KB	Share
MAP	Results of Annual General Meeting		30/11/23	219.28KB	Share
MAP	2023 AGM Presentations		30/11/23	3.31MB	Share
MAP	Change in substantial holding		29/11/23	870.26KB	Share
MAP	Change in substantial holding		28/11/23	271.63KB	Share
MAP	Listing Rule 6.22.2 Adjustment to Option Exercise Prices		28/11/23	140.19KB	Share
MAP	Autoimmune Stage 1 Screening Complete with Gingko Bioworks	PRICE SENSITIVE	28/11/23	4.5MB	Share

MAP Q4 FY25 Quarterly Investor Presentation & Webinar
22/07/25	PRICE SENSITIVE	4.23MB	Share
MAP Q4 FY25 Quarterly Activities Report & Appendix 4C
22/07/25	PRICE SENSITIVE	528.6KB	Share
MAP Details of Q4 FY25 Quarterly Report, Appendix 4C & Webinar
17/07/25		160KB	Share
MAP Letter to Shareholders, Notice of EGM & Proxy Form
08/07/25		902.1KB	Share
MAP Ceasing to be a substantial holder
02/07/25		205.24KB	Share
MAP Cleansing Notice
27/06/25		170.84KB	Share
MAP Letter to SPP Eligible Shareholders
27/06/25		247.16KB	Share
MAP Disclosure Document - Prospectus
27/06/25	PRICE SENSITIVE	891.75KB	Share
MAP Application for quotation of securities - MAP
27/06/25		15.8KB	Share
MAP Reinstatement to Quotation
23/06/25	PRICE SENSITIVE	86.15KB	Share
MAP Proposed issue of securities - MAP
23/06/25		24.4KB	Share
MAP Proposed issue of securities - MAP
23/06/25		16.69KB	Share
MAP Proposed issue of securities - MAP
23/06/25		19.09KB	Share
MAP Proposed issue of securities - MAP
23/06/25		15.57KB	Share
MAP Strategic Investment & Equity Raise Presentation
23/06/25	PRICE SENSITIVE	4.96MB	Share
MAP Microba secures $14.5 million to drive clinical adoption
23/06/25	PRICE SENSITIVE	348.74KB	Share
MAP Suspension from Quotation
23/06/25	PRICE SENSITIVE	270.19KB	Share
MAP Trading Halt
19/06/25	PRICE SENSITIVE	265.94KB	Share
MAP MetaPanel Pathogen Study Delivers Breakthrough Results
21/05/25	PRICE SENSITIVE	246.16KB	Share
MAP Landmark GI Study Results from over 4,600 patients
14/05/25	PRICE SENSITIVE	236.25KB	Share
MAP Notification of cessation of securities - MAP
12/05/25		12.83KB	Share
MAP Q3 FY25 Quarterly Investor Presentation & Webinar
30/04/25	PRICE SENSITIVE	2.83MB	Share
MAP Q3 FY25 Quarterly Activities Report & Appendix 4C
30/04/25	PRICE SENSITIVE	446.4KB	Share
MAP Details of Q3 FY25 Quarterly Report, Appendix 4C & Webinar
28/04/25		139.54KB	Share
MAP HealthInvest 2025 Investor Conference Presentation
02/04/25		2.08MB	Share
MAP Webinar Presentation - Diagnostics Deep Dive - Part A
20/03/25		5.17MB	Share
MAP Diagnostics Growth & Metrics Webinar - Part B
20/03/25		492.81KB	Share
MAP Investor Webinar & Newsletter
04/03/25		240.75KB	Share
MAP Appendix 4D & FY25 Interim Report
26/02/25	PRICE SENSITIVE	2.37MB	Share
MAP Notification of cessation of securities - MAP
19/02/25		12.89KB	Share
MAP Notification of cessation of securities - MAP
19/02/25		12.89KB	Share
MAP Notification regarding unquoted securities - MAP
14/02/25		18.6KB	Share
MAP Q2 FY25 Quarterly Investor Presentation & Webinar
29/01/25	PRICE SENSITIVE	4.05MB	Share
MAP Q2 FY25 Quarterly Activities Report & Appendix 4C
29/01/25	PRICE SENSITIVE	368.92KB	Share
MAP Details of Q2 FY25 Quarterly Report, Appendix 4C & Webinar
23/01/25		145.24KB	Share
MAP Becoming a substantial holder
03/01/25		209.94KB	Share
MAP Amended Constitution
29/11/24		688.99KB	Share
MAP Results of Annual General Meeting
29/11/24		160.8KB	Share
MAP 2024 Annual General Meeting Presentation
29/11/24		3.25MB	Share
MAP Chair, Deputy Chair and CEO Addresses to AGM
29/11/24		226.88KB	Share
MAP Trading Update
29/11/24	PRICE SENSITIVE	167.5KB	Share
MAP Change of Director's Interest Notice - Pasquale Rombola
20/11/24		271.95KB	Share
MAP Change of Director's Interest Notice - Prof Ian Frazer
20/11/24		272KB	Share
MAP Bell Potter Healthcare Conference Presentation
19/11/24		3.56MB	Share
MAP Microba receives $6 million R&D Tax Incentive Refund
18/11/24	PRICE SENSITIVE	166.11KB	Share
MAP Release of Securities from Voluntary Escrow
11/11/24		138.87KB	Share
MAP Q1 FY25 Quarterly Activities Report & Appendix 4C
29/10/24	PRICE SENSITIVE	414.76KB	Share
MAP Q1 FY25 Quarterly Investor Presentation
29/10/24	PRICE SENSITIVE	4.23MB	Share
MAP Annual Report to Shareholders
28/10/24		4MB	Share
MAP Letter to Shareholders, Notice of AGM & Proxy Form
28/10/24		599.75KB	Share
MAP Details of Q1 FY25 Quarterly Report, Appendix 4C & Webinar
23/10/24		145.26KB	Share
MAP Strategic transfer of Microba Research Services Unit to CMC
10/10/24		176.29KB	Share
MAP Date of AGM and Closing Date for Director Nominations
02/10/24		132.53KB	Share
MAP Microba Presents at ASX Small & Mid Cap Conference
25/09/24		3.01MB	Share
MAP Change of Joint Company Secretary Role
02/09/24		132.05KB	Share
MAP 2024 Annual Report & Appendix 4E
29/08/24	PRICE SENSITIVE	4.28MB	Share
MAP 2024 Appendix 4G
29/08/24		287.71KB	Share
MAP 2024 Corporate Governance Statement
29/08/24		240.75KB	Share
MAP Q4 FY24 Quarterly Investor Presentation & Webinar
25/07/24	PRICE SENSITIVE	2.85MB	Share
MAP Q4 FY24 Quarterly Activities Report & Appendix 4C
25/07/24	PRICE SENSITIVE	410.05KB	Share
MAP Details of Q4 FY24 Quarterly Report, Appendix 4C & Webinar
23/07/24		145KB	Share
MAP Microba Diagnostics Business Update to Bioshares Summit
12/07/24		1.36MB	Share
MAP Notification of cessation of securities - MAP
10/07/24		14.82KB	Share
MAP Completion of Autoimmune Program with Ginkgo Bioworks
28/06/24	PRICE SENSITIVE	240.98KB	Share
MAP Release of Securities from Voluntary Escrow
25/06/24		128.08KB	Share
MAP Notification of cessation of securities - MAP
03/06/24		12.88KB	Share
MAP Q3 FY24 Quarterly Investor Presentation
23/04/24	PRICE SENSITIVE	3.8MB	Share
MAP Q3 FY24 Quarterly Activities Report & Appendix 4C
23/04/24	PRICE SENSITIVE	415.6KB	Share
MAP Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar
18/04/24		142.29KB	Share
MAP Microba Launches Investor Hub for Investor Engagement
16/04/24		161.93KB	Share
MAP Microba receives $6.08 million R&D Tax Incentive Refund
10/04/24	PRICE SENSITIVE	156.94KB	Share
MAP Notification of cessation of securities - MAP
10/04/24		12.94KB	Share
MAP Ceasing to be a substantial holder
05/04/24		217.69KB	Share
MAP Application for quotation of securities - MAP
05/04/24		14.34KB	Share
MAP Release of Restricted Securities
25/03/24		150.33KB	Share
MAP MetaPanel Launch Investor Presentation
13/03/24	PRICE SENSITIVE	2.01MB	Share
MAP MetaPanel Diagnostic Test Launched with Sonic Healthcare
13/03/24	PRICE SENSITIVE	252.04KB	Share
MAP Change in substantial holding
04/03/24		270.91KB	Share
MAP Appendix 4D & FY24 Interim Report
28/02/24	PRICE SENSITIVE	2.03MB	Share
MAP Change in substantial holding
26/02/24		230.09KB	Share
MAP Q2 FY24 Quarterly Investor Presentation
30/01/24	PRICE SENSITIVE	4.09MB	Share
MAP Q2 FY24 Quarterly Activities Report & Appendix 4C
30/01/24	PRICE SENSITIVE	381.9KB	Share
MAP Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar
29/01/24		130.4KB	Share
MAP Notification of cessation of securities - MAP
25/01/24		21.78KB	Share
MAP Release of Restricted Securities
19/01/24		150.39KB	Share
MAP Notification regarding unquoted securities - MAP
29/12/23		28.17KB	Share
MAP Change of Director's Interest Notice - Jacqueline Fernley
29/12/23		261.62KB	Share
MAP Successful IBD Phase I Clinical Trial
07/12/23	PRICE SENSITIVE	233.97KB	Share
MAP Cleansing Notice
06/12/23		198.24KB	Share
MAP Application for quotation of securities - MAP
06/12/23		24.98KB	Share
MAP Completion of Acquisition of Invivo Clinical Limited
06/12/23		138.15KB	Share
MAP Proposed issue of securities - MAP
04/12/23		25.31KB	Share
MAP Proposed issue of securities - MAP
04/12/23		25.22KB	Share
MAP Research Agreement Executed with IFF for Allergy Program
04/12/23	PRICE SENSITIVE	168.71KB	Share
MAP Results of Annual General Meeting
30/11/23		219.28KB	Share
MAP 2023 AGM Presentations
30/11/23		3.31MB	Share
MAP Change in substantial holding
29/11/23		870.26KB	Share
MAP Change in substantial holding
28/11/23		271.63KB	Share
MAP Listing Rule 6.22.2 Adjustment to Option Exercise Prices
28/11/23		140.19KB	Share
MAP Autoimmune Stage 1 Screening Complete with Gingko Bioworks
28/11/23	PRICE SENSITIVE	4.5MB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.2¢		Change 0.000(0.00%)		Mkt cap ! $47.38M

Open	High	Low	Value	Volume
9.3¢	9.3¢	9.2¢	$4.641K	50K

Buyers (Bids)

No.	Vol.	Price($)
5	11774	9.2¢

Sellers (Offers)

Price($)	Vol.	No.
9.5¢	114482	1

View Market Depth

No.	Vol.	Price($)
5	11774	0.092
4	60967	0.091
7	405677	0.090
2	192844	0.089
2	12552	0.088

Price($)	Vol.	No.
0.095	114482	1
0.099	195500	2
0.105	103000	1
0.110	1714	1
0.120	195000	1

Last trade - 15.57pm 30/07/2025 (20 minute delay)

MAP (ASX) Chart

MICROBA LIFE SCIENCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available